BioSpace News Archive

Business

ADC Therapeutics and Adagene Team Up to Develop Anti-Cancer Molecules

ADC Therapeutics, based in Lausanne, Switzerland, and Adagene, headquartered in Suzhou, China and San Francisco, announced a discovery collaboration and license deal.

April 24, 2019
·
2 min read
·
Mark Terry
Business

ADC Therapeutics and Adagene Announce License Agreement

ADC Therapeutics to develop next-generation masked antibody drug conjugates (ADCs), incorporating Adagene’s SAFEbody™ technology, with potential utility across multiple tumor types

April 24, 2019
·
4 min read
BioCity invests in carbon recycling start-up, Deep Branch Biotechnology

BioCity, a pioneering life science incubator and business collective, today announced investment in Deep Branch Biotechnology, a Nottingham-based carbon recycling start-up, developing technology that transforms polluters into producers.

April 24, 2019
·
4 min read
Biotech Bay

Reducing care needs of teens with substance-abuse disorders

Kaiser Permanente researchers find long-term benefits for patients and health organizations that employ screenings, interventions, and referrals

April 24, 2019
·
4 min read
Policy

EpimAb Biotherapeutics is Granted US Patent on Core Bispecific Antibody Technology

Patent protects EpimAb’s core technology FIT-Ig® and its entire bispecific pipeline with a broad composition of matter claim

April 24, 2019
·
2 min read
Deals

Ipsen Reports Strong Double-Digit Sales Growth in First Quarter 2019 and Confirms Full Year 2019 Financial Targets

Ipsen, a global specialty-driven biopharmaceutical group, announced its sales for the first quarter of 2019.

April 24, 2019
·
14 min read
Oncopeptides Provides New Guidance on the Patient Recruitment in the OCEAN Study and a Clinical Program Update in a Webcast at 10:00 (CET)

Oncopeptides AB announces that the company will provide an update on patient recruitment in the ongoing phase 3 study OCEAN, as well as a general update from all the company’s clinical studies in a webcast at 10.00am.

April 24, 2019
·
5 min read
Drug Development

Rexgenero Presents Update on Phase III Clinical Trials with REX-001, a Cell-based Therapy for Critical Limb Ischaemia

At the Alliance for Regenerative Medicine’s Cell and Gene Therapy ‘Meeting on the Med’ in Barcelona

April 24, 2019
·
4 min read
Can a novel, temporary, and fully resorbable surgical implant improve the outcome of common hockey and soccer injuries?

Researchers of the Erasmus University Medical Center in Rotterdam − the Netherlands, consider that the synthetic and fully resorbable TIGR® Matrix surgical mesh may reduce frequent risks related to the surgical repair of Sportsman’s hernia.

April 24, 2019
·
2 min read
Deals

Aptorum Group Limited Announces Repurchase of USD13,500,000 Outstanding Convertible Bonds Due 2019

Aptorum Group Limited announced that the Company, in a privately-negotiated transaction, repurchased all outstanding US$13,500,000 in aggregate principal amount of the 8.00 per cent.

April 24, 2019
·
4 min read